Substance / Medication

Propamidine

Overview

Active Ingredient
propamidine
RxNorm CUI
34633

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
[Acanthamoeba keratitis, a possible dibromo propamidine isethionate resistance].
Vaquero Ruano M, Encinas Martín J L, Ramón Y Cajal S et al. · Arch Soc Esp Oftalmol · 2002
PMID: 12023748Case Report
Synergistic Effect and Water-Dispersible Tablet of Propamidine and Flusilazole Against.
Qiao Yonghui, Xu Guanyou, Liu Xiaoxiao et al. · Plant Dis · 2025
PMID: 40434963Other
Effectiveness of Polyclonal Antibody Immunoconjugate Treatment with Propamidine Isethionate for Amoebic Keratitis in Golden Hamsters.
Ávila-Blanco Manuel Enrique, Aguilera-Martínez Sandra Lizbeth, Ventura-Juarez Javier et al. · J Parasitol Res · 2023
PMID: 37143958OtherFull text (PMC)
Biochemical and genetic characterization of Botrytis cinerea laboratory mutants resistant to propamidine.
Zhang Xuhuan, Huang Ke, Zhang Mengwei et al. · Pest Manag Sci · 2022
PMID: 36054525Other
Baseline Sensitivity and Action Mechanism of Propamidine Against, the Causal Agent of Dark Leaf Spot on Cabbage.
Wang Yong, Wang Miaomiao, Zhou Mingxia et al. · Plant Dis · 2020
PMID: 31697222Other
Baseline sensitivity and biochemical responses of Valsa mali to propamidine.
Wang Yong, Sun Yang, Xiong Zi et al. · Pestic Biochem Physiol · 2018
PMID: 29933998Other
The Orphan Drug for Acanthamoeba Keratitis (ODAK) Trial: PHMB 0.08% (Polihexanide) and Placebo versus PHMB 0.02% and Propamidine 0.1.
Dart John K G, Papa Vincenzo, Rama Paolo et al. · Ophthalmology · 2024
PMID: 37802392Trial
Synthesis, Screening and in silico Simulations of Anti-Parasitic Propamidine/Benzimidazole Derivatives.
Mendez-Cuesta Carlos A, Herrera-Rueda Miguel A, Hidalgo-Figueroa Sergio et al. · Med Chem · 2017
PMID: 27527618Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Propamidine (substance)
SNOMED CT
395996003
UMLS CUI
C0072159
RxNorm CUI
34633

Clinical Data

This intervention maps to 1 entities in the Ltrl knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.